A novel therapeutic may halt rapid kidney function in some type 1 diabetic kidney disease patients.
Research finds juvenile myositis and lupus share an inflammatory pathway, but their pathophysiological differences may serve as diagnostic biomarkers in future studies.
A new potential biomarker raises concerns over the current standard for treating COVID-19 induced blood clots with high dose blood thinners.
People whose blood pressure is hard to control might have another condition that’s the real culprit. So why aren’t they being tested for primary aldosteronism?